HLA and T-cell receptor gene polymorphisms in Guillain-Barre syndrome

Neurology

Volumn 51, Issue 2, 1998, Pages 379-384

  Ma, J J ^a   Nishimura, M ^a   Mine, H ^d   Kuroki, S ^d   Nukina, M ^d   Ohta, M ^a   Saji, H ^d   Obayashi, H ^d   Saida, T ^a   Kawakami, H ^b   Uchiyama, T ^c  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLELE; ARTICLE; BETA CHAIN; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENTERITIS; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GUILLAIN BARRE SYNDROME; HEREDITY; HLA SYSTEM; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NERVE CONDUCTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0031754188     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.2.379     Document Type: Article

References (36)

1. Stewart GJ, Pollard JD, McLeod JG, Wolnitzer CM. HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis. Ann Neurol 1978;4:285-289.
2. Winer JB, Briggs D, Welsh K, Hughes RAC. HLA antigens in the Guillain-Barré syndrome. J Neuroimmunol 1988;18: 13-16.
3. Hillert J, Osterman PO, Olerup O. No association with HLA-DR, -DQ or -DP alleles in Guillain-Barr syndrome. J Neuroimmunol 1991;31:67-72.
4. Piradov MA, Dolbin AG, Voylokova RY, Yazdovsky VV. HLA antigens in severe forms of Guillain-Barré syndrome. Neurology 1995;45:1419-1420.
5. Rees JH, Vaughan RW, Kondeatis E, Hughes RAC. HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J Neuroimmunol 1995;62:53-57.
6. Kaldor J, Speed DR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J 1984;288:1867-1870.
7. Winer JB, Hughes RAC, Anderson MJ, Lones DM, Kangro H, Watkins RPF. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988;51:613-618.
8. Monos DS, Papaioakim M, Ho TW, Li CY, McKhann GM. Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome. J Infect Dis 1997;176(suppl 2): S180-S182.
9. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-144.
10. Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barr syndrome and controls: correlation and prognosis. Ann Neurol 1993;34:130-135.
11. Jacobs BC, van Doom PA, Schmitz PIM, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol 1996;40:181-187.
12. Frank CA, Olsen ML, Anderson KL, Reville JD. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 1991;87:1490-1495.
13. Kuwana M, Kaburaki J, Okano Y, Inoko H, Tsuji K. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 1993;92:1296-1301.
14. Utiger RD. The pathogenesis of autoimmune thyroid disease. N Engl J Med 1991;325:278-279.
15. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):S21-S24.
16. Kuroki S, Saida T, Nukina M, et al. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann Neurol 1993;33:243-247.
17. Kuroki S, Haruta T, Yoshioka M, Kobayashi Y, Nukina M, Nakanishi H. Guillain-Barré syndrome associated with Campylobacter jejuni infection. Pediatr Infect Dis J 1991;10: 149-151.
18. Cornelis F, Hashimoto L, Loveridge J, et al. Identification of a CA repeat at the TCRA locus using yeast artificial chromosomes: a general method for generating highly polymorphic markers at chosen loci. Genomics 1992;13:820-825.
19. Droogan AG, Kirk CW, Hawkins SA, McMillan SA, Nevin NC, Graham CA. T-cell receptor alpha, beta, gamma, and delta chain gene microsatellites show no association with multiple sclerosis. Neurology 1996;47:1049-1053.
20. Charmley P, Concannon P. Polymorphism and phylogeny of dinucleotide repeats in human T-cell receptor Vb6 genes. Immunogenetics 1993;38:92-97.
21. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-1213.
22. Gomolka M, Hundrieser J, Nürnberg P, Roewer L, Epplen JT, Epplen C. Selected di- and tetranucleotide microsatellites from chromosomes 7, 12, 14, and Y in various Eurasian populations. Hum Genet 1994;93:592-596.
23. Mu H, Charmley P, King MC, Criswell LA. Synergy between T cell receptor β gene polymorphism and HLA-DR4 in susceptibility to rheumatoid arthritis. Arthritis Rheum 1996;39:931-937.
24. Ota M, Seki T, Fukushima H, Tsuji K, Inoko H. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1992;39:187-202.
25. Nomura N, Ota M, Tsuji H, Inoko H. HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1991;38:53-59.
26. Yuki N, Sato S, Fujimoto S, et al. Serotype of Campylobacter jejuni, HLA and the Guillain-Barr syndrome. Muscle Nerve 1992;15:968-969.
27. Naito S, Tabira T, Kuroiwa Y. HLA studies of multiple sclerosis in Japanese. In: Kuroiwa Y, Kurland LT, eds. Multiple sclerosis East and West. Fukuoka: Kyushu University Press, 1982:215-222.
28. Fujimoto S, Yuki Y, Itoh T, Amako K. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome. J Infect Dis 1992:165:183.
29. Enders U, Karch H, Toyka KV, Heesemann J, Hartung HP. Campylobacter jejuni and Guillain-Barré syndrome. Ann Neurol 1994;35:249.
30. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barr syndrome. N Engl J Med 1995;333:1374-1379.
31. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-1775.
32. Nishimura M, Nukina M, Kuroki S, et al. Characterization of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome. J Neurol Sci 1997;153:91-99.
33. Böhme J, Andersson M, Andersson G, Möller E, Peterson PA, Rask L. HLA-DR β genes vary in number between different DR specificities, whereas the number of DQ β genes is constant. J Immunol 1985;135:2149-2155.
34. Ragoussis J, Monaco A, Mockridge I, Kendall E, Campbell RD, Trowsdale J. Cloning of the HLA class II region in yeast artificial chromosomes. Proc Natl Acad Sci USA 1991;88: 3753-3757.
35. Epplen C, Jäckel S, Santos EJM, et al. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol 1997;41:341-352.
36. Khalili-Shirazi A, Gregson NA, Hall MA, Hughes RAC, Lanchbury JS. T cell receptor Vβ gene usage in Guillain-Barré syndrome. J Neurol Sci 1997;145:169-176.